🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,469

Quick answer

1,469 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7670855

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7666581

    Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease

    University of Connecticut Health Center · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7666427

    HIV vaccines based on Env of multiple clades of HIV

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7666619

    Compounds and methods for regulating bacterial growth and pathogenesis

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7662779

    Triazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7662607

    Chalaropsis lysozyme protein and its method of use in anti-bacterial applications

    New Century Pharmaceuticals, Inc. · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7662999

    Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases

    The United States of America as represented by the Department of Health and Human Services (DHHS) · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7655247

    Malaria vaccines

    The Government of the United States, as Respresented by the Secretary of the Army · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7645881

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7645732

    Treating hepatitis C virus infection

    The Board of Regents of the University of Texas System · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7638269

    Viral capsid assembly intermediates and methods of production

    The Regents of the University of California · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7635476

    Anti-hepatitis a virus antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7635688

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7635683

    Quinoxalinyl tripeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7625871

    Indole antiviral compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7618623

    Hybrid adeno-retroviral vector for the transfection of cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7611885

    Pharmaceutically compatible method for purifying intact bacterial minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7612093

    Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapy

    United Therapeutics Corporation · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7611704

    Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7605126

    Acylaminoheteroaryl hepatitis C virus protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7601709

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7601490

    Development of influenza A antivirals

    The Board of Regents of the University of Texas System · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7601735

    Antiviral compounds

    Airgain, Inc. · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7589075

    Use of an adenosine A3 receptor agonist for inhibition of viral replication

    CAN-FITE BIOPHARMA LTD. · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7582605

    Phosphorus-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7572828

    Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7566465

    Artemisinins in the clinical and veterinary management of kinetoplastid infections

    The United States of America as represented by the Secretary of the Army · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7566732

    Rhodanine compositions for use as antiviral agents

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7566719

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7553490

    Vaccines against Escherichia coli O157 infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7537765

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7534613

    Methods of treating parkinson's disease using viral vectors

    The Regents of the University of California · Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7528274

    Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7521418

    Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent

    Theravance, Inc. · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7514410

    Hepatitis C therapies

    BioCryst Pharmaceuticals, Inc. · Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7511124

    Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7501494

    Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

    United Biomedical, Inc. · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7498353

    Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Mar 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7494988

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7479484

    Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7470430

    Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7455833

    Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7452861

    Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

    Theravance, Inc. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7452544

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7432047

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7429485

    Method of producing infectious reovirus

    ONCOLYTICS BIOTECH INC. · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7425611

    Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7417136

    Nucleic acid vaccines for prevention of flavivirus infection

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Infectious disease patents are indexed?

1,469 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.